Results 11 to 20 of about 247,714 (344)

Drug-coated balloon versus conventional balloon angioplasty of hemodialysis arteriovenous fistula or graft: A systematic review and meta-analysis of randomized controlled trials

open access: yesPLoS ONE, 2020
Background Restenosis remains a significant problem in endovascular therapy for hemodialysis vascular access. Drug-coated balloon (DCB) angioplasty decreases restenosis in peripheral and coronary artery diseases.
Min‐Tsun Liao   +7 more
semanticscholar   +1 more source

Impact of Stepwise Balloon Angioplasty for De Novo Femoropopliteal Artery: A Retrospective Observational Study. [PDF]

open access: yesHealth Sci Rep
ABSTRACT Background and Aims Drug‐coated balloon use in the revascularisation of femoropopliteal (FP) lesions improves patency rates. However, conventional balloon angioplasty sometimes leads to severe artery dissection, which may be prevented using stepwise balloon angioplasty.
Tokuda T   +8 more
europepmc   +2 more sources

Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis [PDF]

open access: yes, 2007
Background: Meta-analyses of trials have shown greater benefits from angioplasty than thrombolysis after an acute myocardial infarction, but the time delay in initiating angioplasty needs to be considered.
Abrams, Keith R.   +6 more
core   +4 more sources

Long-Term Outcomes of Invasive vs Noninvasive Treatment for Intermittent Claudication: A Systematic Review and Meta-Analysis. [PDF]

open access: yesCochrane Evid Synth Methods
In patients with leg pain from blocked arteries (intermittent claudication), this study shows that surgical procedures improve walking ability and blood flow more than exercise or medication alone but carry higher risks. The findings help guide doctors and patients in choosing the best treatment based on individual needs and risks.
Elmahi A   +9 more
europepmc   +2 more sources

Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis [PDF]

open access: yes, 2007
Objective: To assess the cost effectiveness of primary angioplasty, compared with medical management with thrombolytic drugs, to achieve reperfusion after acute myocardial infarction ( AMI) from the perspective of the UK NHS.
Abrams, Keith   +6 more
core   +2 more sources

S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty [PDF]

open access: yes, 2002
Background: The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period.
Clifton, A.   +4 more
core   +1 more source

ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data. [PDF]

open access: yes, 2013
A number of risk scores already exist to predict cardiovascular (CV) events. However, scores developed with data collected some time ago might not accurately predict the CV risk of contemporary hypertensive patients that benefit from more modern ...
A K Gupta   +27 more
core   +1 more source

Measurement of pressure and assessment of cavitation for a 22.5-kHz intra-arterial angioplasty device [PDF]

open access: yes, 1996
This study was performed to understand better the mechanisms of action of an (22.5 kHz) ultrasonic wire catheter device used to remove atheromatous plaque in diseased blood vessels (ultrasonic angioplasty).
Everbach, E. Carr, Makin, I. R. S.
core   +2 more sources

Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2018
BACKGROUND Restenosis remains a problem in hemodialysis access interventions. Paclitaxel-coated balloons have shown promise in reducing access-related restenosis in small trials.
S. Trerotola   +3 more
semanticscholar   +1 more source

Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. [PDF]

open access: yes, 2014
Cardiovascular disease remains one of the largest contributors to death worldwide. Improvements in cardiovascular technology leading to the current generation of drug-eluting stents, bioresorbable stents, and drug-eluting balloons, coupled with advances ...
Panitch, Alyssa, Scott, Rebecca A
core   +2 more sources

Home - About - Disclaimer - Privacy